drugset / Trial / NCT03853993
Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of quadrivalent influenza vaccine in healthy subjects aged over 3 years
Timeline
- Start
- 2018-01-23
- Primary completion
- 2018-08-17
- Completion
- 2018-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quadrivalent influenza vaccine | Vaccine | 15 ug | — |
| Comparator | Trivalent influenza vaccine (contains B/Victoria strain) | Vaccine | 15 ug | — |
| Comparator | Trivalent influenza vaccine (contains B/Yamagata strain) | Vaccine | 15 ug | — |